Press Releases

Sign up for Email Alerts Press Release RSS

03/06/2019
Bristol-Myers Squibb to Take Part in the Barclays 2019 Global Healthcare Conference
Term:Corporate/Financial News
Language:English
03/06/2019
Bristol-Myers Squibb Files Investor Presentation and Board of Directors Sends Letter to Shareholders Regarding Pending Transaction with Celgene
Term:Corporate/Financial News
Language:English
03/05/2019
Bristol-Myers Squibb to Take Part in the Cowen and Company 39th Annual Health Care Conference
Term:Corporate/Financial News
Language:English
02/28/2019
Bristol-Myers Squibb Issues Statement in Response to Starboard’s Letter
Term:Corporate/Financial News
Language:English
02/22/2019
Bristol-Myers Squibb Announces Filing of Definitive Proxy Statement in Connection with Proposed Merger with Celgene
Term:Corporate/Financial News
Language:English
02/20/2019
Bristol-Myers Squibb Provides Update on Pending Transaction with Celgene
Term:Corporate/Financial News
Language:English
02/14/2019
Opdivo (nivolumab) Plus Yervoy (ipilimumab) Shows Response in Pre-Treated Patients with Metastatic Castration-Resistant Prostate Cancer
Term:Corporate/Financial News
Language:English
02/11/2019
Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) Demonstrates Continued Survival Benefit at 30-Month Follow-up in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
Term:Corporate/Financial News
Language:English
02/11/2019
European Commission Approves Bristol-Myers Squibb’s Sprycel (dasatinib) in Combination with Chemotherapy for Treatment of Pediatric Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Term:Corporate/Financial News
Language:English
02/07/2019
Bristol-Myers Squibb to Take Part in Guggenheim Healthcare Talks Idea Forum
Term:Corporate/Financial News
Language:English

Business Wire NewsHQ^sm